These adaptive T cells, particularly CD8+ CTLs, mediate tumor cell killing through antigen-specific recognition of tumor-associated antigens (TAAs) or neoantigens, eliciting potent cytotoxic molecular mediators capable of direct tumor lysis. This evidence concerns the gene CD8A and neoplasm.